KR900006237B1 - 항생물질 화합물의 제조방법 - Google Patents

항생물질 화합물의 제조방법 Download PDF

Info

Publication number
KR900006237B1
KR900006237B1 KR1019850000008A KR850000008A KR900006237B1 KR 900006237 B1 KR900006237 B1 KR 900006237B1 KR 1019850000008 A KR1019850000008 A KR 1019850000008A KR 850000008 A KR850000008 A KR 850000008A KR 900006237 B1 KR900006237 B1 KR 900006237B1
Authority
KR
South Korea
Prior art keywords
erythromycin
stearate
acetyl
ethyl acetate
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
KR1019850000008A
Other languages
English (en)
Korean (ko)
Other versions
KR850005452A (ko
Inventor
라울리 안테로 마볼라 마티
베이코 마틸라 에스코
안테로 우오틸라 야아코
킬리키 피푸리 아이노
유하니 카이리살로 페카
유하니 혼카넨 에르키
Original Assignee
오리온 위티머 오위
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 오리온 위티머 오위 filed Critical 오리온 위티머 오위
Publication of KR850005452A publication Critical patent/KR850005452A/ko
Application granted granted Critical
Publication of KR900006237B1 publication Critical patent/KR900006237B1/ko
Expired legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Coloring (AREA)
KR1019850000008A 1984-01-06 1985-01-04 항생물질 화합물의 제조방법 Expired KR900006237B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DK58 1984-01-06
DK5884A DK149776C (da) 1984-01-06 1984-01-06 Antibiotisk virksom erytromycinforbindelse og praeparat indeholdende forbindelsen
DK85 1984-01-06

Publications (2)

Publication Number Publication Date
KR850005452A KR850005452A (ko) 1985-08-26
KR900006237B1 true KR900006237B1 (ko) 1990-08-27

Family

ID=8089251

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019850000008A Expired KR900006237B1 (ko) 1984-01-06 1985-01-04 항생물질 화합물의 제조방법

Country Status (38)

Country Link
US (1) US4599326A (enExample)
JP (1) JPS60158197A (enExample)
KR (1) KR900006237B1 (enExample)
AT (1) AT386414B (enExample)
AU (1) AU565688B2 (enExample)
BE (1) BE901411A (enExample)
BG (1) BG43189A3 (enExample)
CA (1) CA1224461A (enExample)
CH (1) CH666275A5 (enExample)
CS (1) CS247191B2 (enExample)
CY (1) CY1462A (enExample)
DE (1) DE3500179A1 (enExample)
DK (1) DK149776C (enExample)
ES (1) ES8605818A1 (enExample)
FI (1) FI77249C (enExample)
FR (1) FR2557878B1 (enExample)
GB (1) GB2152502B (enExample)
HK (1) HK11590A (enExample)
HU (1) HU196221B (enExample)
IE (1) IE57967B1 (enExample)
IL (1) IL73885A (enExample)
IS (1) IS2968A7 (enExample)
IT (1) IT1184304B (enExample)
KE (1) KE3841A (enExample)
LU (1) LU85721A1 (enExample)
MA (1) MA20316A1 (enExample)
MX (1) MX156277A (enExample)
NL (1) NL8403979A (enExample)
NO (1) NO160263C (enExample)
NZ (1) NZ210606A (enExample)
PH (1) PH22471A (enExample)
PL (1) PL144349B1 (enExample)
PT (1) PT79777B (enExample)
RO (1) RO91262B (enExample)
SE (1) SE461854B (enExample)
SU (1) SU1410866A3 (enExample)
YU (1) YU44485B (enExample)
ZA (1) ZA8410143B (enExample)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4863741A (en) * 1985-03-25 1989-09-05 Abbott Laboratories Tablet composition for drug combinations
US4874614A (en) * 1985-03-25 1989-10-17 Abbott Laboratories Pharmaceutical tableting method
JP3382159B2 (ja) * 1998-08-05 2003-03-04 株式会社東芝 情報記録媒体とその再生方法及び記録方法
US8840928B2 (en) 2002-07-05 2014-09-23 Collegium Pharmaceutical, Inc. Tamper-resistant pharmaceutical compositions of opioids and other drugs
WO2004004693A1 (en) * 2002-07-05 2004-01-15 Collgegium Pharmaceutical Abuse-deterrent pharmaceutical compositions of opiods and other drugs
US10004729B2 (en) 2002-07-05 2018-06-26 Collegium Pharmaceutical, Inc. Tamper-resistant pharmaceutical compositions of opioids and other drugs
US20050163849A1 (en) * 2003-10-31 2005-07-28 Wong Patrick S. Compositions and dosage forms for enhanced absorption of iron
CA2569958C (en) 2004-06-12 2016-03-22 Jane C. Hirsh Abuse-deterrent drug formulations
US9895444B2 (en) 2004-08-25 2018-02-20 Aegis Therapeutics, Llc Compositions for drug administration
EP2457580A1 (en) 2004-08-25 2012-05-30 The UAB Research Foundation Absorption enhancers for drug administration
EP2076281A4 (en) 2006-06-23 2010-03-03 Aegis Therapeutics Inc STABILIZING ALKYLGLYCOSIDIC COMPOSITIONS AND METHODS THEREOF
US10668060B2 (en) 2009-12-10 2020-06-02 Collegium Pharmaceutical, Inc. Tamper-resistant pharmaceutical compositions of opioids and other drugs
WO2012158962A2 (en) 2011-05-18 2012-11-22 Eumederis Pharmaceuticals, Inc. Improved peptide pharmaceuticals
JP6525456B2 (ja) 2012-11-20 2019-06-05 メデリス ダイアビーティーズ，エルエルシー インスリン抵抗性のための改善されたペプチド製剤
WO2014081864A1 (en) 2012-11-20 2014-05-30 Eumederis Pharmaceuticals, Inc. Improved peptide pharmaceuticals
WO2014140699A1 (en) * 2013-03-13 2014-09-18 Calyx Chemicals And Pharmaceuticals Ltd A novel process of liberation of erythromycin and preparation of its salts
US9856306B2 (en) 2014-05-28 2018-01-02 Spitfire Pharma, Inc. Peptide pharmaceuticals for insulin resistance
WO2017222575A1 (en) 2016-06-23 2017-12-28 Collegium Pharmaceutical, Inc. Process of making more stable abuse-deterrent oral formulations
PH12019502594A1 (en) * 2017-05-19 2020-10-26 Lunella Biotech Inc Antimitoscins: targeted inhibitors of mitochondrial biogenesis for eradicating cancer stem cells
CA3083487A1 (en) 2017-12-01 2019-06-06 Lunella Biotech, Inc. Repurposcins: targeted inhibitors of mitochondrial biogenesis for eradicating cancer stem cells
PL3678649T3 (pl) 2018-02-06 2023-05-08 Aegis Therapeutics, Llc Donosowe formulacje epinefryny i sposoby leczenia choroby
JP6941224B2 (ja) 2018-02-06 2021-09-29 イージス セラピューティクス，エルエルシー 疾患の処置のための鼻腔内エピネフリン製剤及び方法
SG11202106532WA (en) * 2018-12-17 2021-07-29 Lunella Biotech Inc Triple combination therapies for anti-aging
MX2021007345A (es) * 2018-12-17 2021-07-15 Lunella Biotech Inc Terapias de combinacion triple para fijar como objetivo mitocondrias y aniquilar celulas madre cancerosas.

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1011117B (de) * 1953-11-16 1957-06-27 Abbott Lab Verfahren zur Herstellung von reinen stabilen Erythromycin-Saeure-Additionssalzen
FR1179208A (fr) * 1953-11-16 1959-05-21 Abbott Lab Procédé de préparation de sels d'érythromycine
GB834397A (en) * 1958-07-29 1960-05-04 Lilly Co Eli Therapeutic compositions comprising erythromycin esters
US4150220A (en) * 1977-02-04 1979-04-17 Pfizer Inc. Semi-synthetic 4"-erythromycin A derivatives
FR2473525A1 (fr) * 1980-01-11 1981-07-17 Roussel Uclaf Nouvelles oximes derivees de l'erythromycine, leur procede de preparation et leur application comme medicaments

Also Published As

Publication number Publication date
NO850007L (no) 1985-07-08
ATA985A (de) 1988-01-15
DE3500179A1 (de) 1985-07-18
PH22471A (en) 1988-09-12
DK5884A (da) 1985-07-07
SE461854B (sv) 1990-04-02
NZ210606A (en) 1987-08-31
NO160263B (no) 1988-12-19
MX156277A (es) 1988-08-04
IE850022L (en) 1985-07-06
DK149776B (da) 1986-09-29
HU196221B (en) 1988-10-28
RO91262B (ro) 1987-07-01
IT1184304B (it) 1987-10-28
CY1462A (en) 1989-07-21
FR2557878A1 (fr) 1985-07-12
CA1224461A (en) 1987-07-21
AU565688B2 (en) 1987-09-24
PL251457A1 (en) 1985-11-05
AT386414B (de) 1988-08-25
SU1410866A3 (ru) 1988-07-15
RO91262A (ro) 1987-06-30
FI850023L (fi) 1985-07-07
IS2968A7 (is) 1985-04-03
GB8432368D0 (en) 1985-02-06
HUT37628A (en) 1986-01-23
US4599326A (en) 1986-07-08
KE3841A (en) 1989-04-07
PL144349B1 (en) 1988-05-31
ZA8410143B (en) 1985-08-28
GB2152502A (en) 1985-08-07
SE8406671D0 (sv) 1984-12-28
YU2085A (en) 1987-12-31
AU3705984A (en) 1985-07-11
DE3500179C2 (enExample) 1989-08-24
FR2557878B1 (fr) 1988-01-15
BE901411A (fr) 1985-04-16
CS247191B2 (en) 1986-12-18
DK149776C (da) 1987-04-21
LU85721A1 (fr) 1985-07-24
JPH029040B2 (enExample) 1990-02-28
ES8605818A1 (es) 1986-04-01
DK5884D0 (da) 1984-01-06
GB2152502B (en) 1987-10-07
IE57967B1 (en) 1993-06-02
PT79777B (en) 1986-10-21
IT8519012A0 (it) 1985-01-04
CH666275A5 (de) 1988-07-15
ES539349A0 (es) 1986-04-01
NO160263C (no) 1989-03-29
IL73885A0 (en) 1985-03-31
MA20316A1 (fr) 1985-10-01
SE8406671L (sv) 1985-07-07
YU44485B (en) 1990-08-31
FI850023A0 (fi) 1985-01-03
FI77249B (fi) 1988-10-31
FI77249C (fi) 1989-02-10
BG43189A3 (en) 1988-04-15
HK11590A (en) 1990-02-23
NL8403979A (nl) 1985-08-01
JPS60158197A (ja) 1985-08-19
PT79777A (en) 1985-01-01
IL73885A (en) 1988-10-31
KR850005452A (ko) 1985-08-26

Similar Documents

Publication Publication Date Title
KR900006237B1 (ko) 항생물질 화합물의 제조방법
DK175544B1 (da) Anvendelse af azithromycin og derivater deraf til fremstilling af antiprotozoale lægemidler
JPS63258841A (ja) チロシン誘導体及びその用途
JP3560653B2 (ja) イツリンａの製造法及び抗深在性真菌症剤
HU197770B (en) Process for producing the new 9-square brackets open (2'r, 3'r, 4's)-3',4'-bis(hydroxymethyl)-2'-oxetanyl square brackets closed-hypoxanthine and pharmaceutical compositions comprising same as active ingredient
SU818492A3 (ru) Способ получени деоксинаразино-ВОгО АНТибиОТичЕСКОгО КОМплЕКСА
US5316769A (en) Drug for preventing and treating fish diseases
JPWO1991009611A1 (ja) 魚病の予防，治療剤
EP0153718B1 (en) Laidlomycin phenylcarbamate
US3956277A (en) Purine sugar derivatives
GB1577545A (en) Treatment of swine dysenter
US4192887A (en) Ruminant coccidiostats
US4168272A (en) Homologs of lasalocid A
EP0024189B1 (en) Acylated laidlomycin derivatives, their preparation and compositions
US3996356A (en) Composition containing 5-sulfanilamido-3,4-dimethylisoxazole and a trimethoxybenzyl pyrimidine
US3068264A (en) Tetracycline antibiotic-aluminumphosphoric acid complexes
JP2540292B2 (ja) 新規な微生物
US3000874A (en) Sulfate salt of erythromycin monoester
US3013942A (en) Therapeutic erythromycin ester compositions
US2608506A (en) Arylsulfamyl benzoic acids
JPS6234038B2 (enExample)
US3291688A (en) Anthelmintic tetrahydropyrimidines
CA1144178A (en) Salts of 2,3-dichloro-4-(hydroxybenzoyl) phenoxyacetic acid
JPS5950318B2 (ja) 新規抗生物質ｓｙ−２物質
JPS6046087B2 (ja) コクシジウム症予防治療剤

Legal Events

Date Code Title Description
PA0109 Patent application

St.27 status event code: A-0-1-A10-A12-nap-PA0109

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

A201 Request for examination
PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

G160 Decision to publish patent application
PG1605 Publication of application before grant of patent

St.27 status event code: A-2-2-Q10-Q13-nap-PG1605

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U11-oth-PR1002

Fee payment year number: 1

FPAY Annual fee payment

Payment date: 19930826

Year of fee payment: 4

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 4

LAPS Lapse due to unpaid annual fee
PC1903 Unpaid annual fee

St.27 status event code: A-4-4-U10-U13-oth-PC1903

Not in force date: 19940828

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

PC1903 Unpaid annual fee

St.27 status event code: N-4-6-H10-H13-oth-PC1903

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 19940828

PN2301 Change of applicant

St.27 status event code: A-5-5-R10-R13-asn-PN2301

St.27 status event code: A-5-5-R10-R11-asn-PN2301

PN2301 Change of applicant

St.27 status event code: A-5-5-R10-R13-asn-PN2301

St.27 status event code: A-5-5-R10-R11-asn-PN2301